Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 135Small Cell Lung Carcinoma 51Lung Neoplasms 45Melanoma 15Carcinoma, Renal Cell 14Carcinoma, Transitional Cell 10Stomach Neoplasms 9Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Hepatocellular 9Mesothelioma, Malignant 8Colorectal Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Breast Neoplasms 6Uterine Cervical Neoplasms 5Neoplasm Metastasis 5Kidney Neoplasms 5Carcinoma, Merkel Cell 5Thoracic Neoplasms 4Carcinoma, Neuroendocrine 4Small Cell Lung Cancer Extensive Stage 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma 3Lung Diseases 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Brain Neoplasms 3

Interventions

Cyclophosphamide 7pembrolizumab 6Radiotherapy 6Cisplatin 6Sunitinib 5Carboplatin 5Paclitaxel 4Thymectomy 3130-nm albumin-bound paclitaxel 3selinexor 2lenvatinib 2fludarabine 2Taxes 2Robotic Surgical Procedures 2Ramucirumab 2Prednisone 2Pemetrexed 2Octreotide 2Nivolumab 2N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2Methylprednisolone 2Imatinib Mesylate 2Etoposide 2Erlotinib Hydrochloride 2Drug Therapy 2Doxorubicin 2Chemoradiotherapy 2Celecoxib 2zimberelimab 1vorolanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × atezolizumab × Thoracic × Clear all
NCT04321330 2024-06-11

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Hoffmann-La Roche

Phase 2 Completed
34 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡